Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA - In vitro and in vivo studies

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 1, 1997, Pages 25-33

  Liao, Yong ^a   Tang, Zhao You ^a   Liu, Kang Da ^a   Ye, Sheng Long ^a   Huang, Zheng ^b  

^a FUDAN UNIVERSITY   (China)

^b Academic Journal of Second Military   (China)

Author keywords

Antisense oligodeoxynucleotides; Apoptosis; H ras; Human hepatoma

Indexed keywords

COMPLEMENTARY DNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; ONCOGENE H RAS; PRIORITY JOURNAL;

EID: 0031060535     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01212611     Document Type: Article

References (85)

1. Ansari B, Coates PJ, Greenstein BD, Hall PA (1993) In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170:1-8
2. Arends MJ, McGregor AH, Toft NJ, Brown EJH, Wyllie AH (1993) Susceptibility to apoptosis is differentially regulated by c-myc and Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 68:1127-1133
3. Arends MJ, McGregor AH, Wyllie AH (1994) Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol 144:1045-1057
4. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779-927
5. Bernards A (1995) Neurofibromatosis type 1 and Ras-mediated signalling: filling in the gaps. Biochim biophys Acta 1242:43-59
6. Bissonnette RP, Echeverri F, Mahboubi A, Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554
7. Bos JL (1988) The ras gene family and human carcinogenesis. Mutat Res 195:255-271
8. Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49:4682-4689
9. Bos JL (1995) P21Ras: an oncoprotein functioning in growth factor-induced signal transduction. Eur J Cancer 31A:1051-1054
10. Burt RK, Garfield S, John K, Thorgeirsson SS (1988) Transformation of rat liver epithelial cells with v-Ha-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis 9:2329-2332
11. Calabretta B, Skorski T, Szczylik C, Zon G (1993) Prospects for gene-directed therapy with antisense oligodeoxynucleotides. Cancer Treat Rev 19:169-179
12. Carson DN, Riboro JM (1993) Apoptosis and disease. Lancet 341:1251-1254
13. Carter G, Lemoine NR (1993) Antisense technology for cancer therapy: does it make sense? Br J Cancer 67:869-876
14. Charlotte F, Lermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES (1994) Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 144:460-465
15. Chen CH, Zhung J, Ling CC (1994) Transfected c-myc and c-Ha-ras modulate radiation-induced apoptosis in rat embryo cells. Radiat Res 139:307-315
16. Chen FH, Xia QJ, Li YX (1991) RNA-RNA in situ hybridization for study of expression of c-myc and H-ras-1 genes in human primary liver cell carcinoma. Tumor (Shanghai) 11:193-194
17. Cheng RM, Chu TH, Yeh HJ, et al. (1979) Establishment of three human hepatocellular carcinoma cell lines cultured in vitro and their characteristics. China Sci 12:1225-1233
18. Chin KV, Ueda K, Pastan I, Gottesman MM (1992) Modulation of activity of the promotor of the human MDR1 gene by ras and p53. Science 255:459-462
19. Clarke AR, Purdie CA, Harrison DJ, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852
20. Cohen JJ (1993) Apoptosis. Immunol Today 14:126-130
21. Collins MKL, Revas AL (1993) The control of apoptosis in mammalian cells. Trends Biol Sci 18:307-309
22. Compton MM (1992) A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev 11:105-119
23. Crook AT (1993) Progress toward oligonuleotide therapeutics pharmacodynamic properties. FASEB J 7:533-539
24. Eastman A (1995) Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin Cancer Biol 6:45-53
25. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128
26. Fanidi A, Harrington EA, Aevan GI (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554-556
27. Fernandez A, Fosdick LJ, Marin MC, Diaz C, McDonnell TJ, Ananthaswamy HN, McConkey DJ (1995) Differential regulation of endogenous endonuclease activation in isolated murine fibroblast nuclei by ras and bcl-2. Oncogene 10: 769-774
28. Fernandez-Sarabia MJ, Bishoff JR (1994) bcl-2 associated with the ras-related protein R-ras p23. Nature 366:274-275
29. Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interaction induces apoptosis. J Cell Biol 124:619-626
30. Gray GD, Hernandez OM, Hebel D, Root M, Pow-Sang JM, Wickstrom E (1993) Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice. Cancer Res 53:577-580
31. Greig RG, Koestler TP, Trainer DL, Corwin SP, Miles L, Kline T, Sweet R, Yokoyama S, Poste G (1985) Tumorigenic and metastatic properties of normal and ras-transfected NIH 3T3 cells. Proc Natl Acad Sci USA 82:3698-3701
32. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F (1995) Fas-induced apoptosis is mediated via a ceramide-initiates Ras signaling pathway. Immunity 2:341-351
33. Harrington EA, Fanidi A, Evan GI (1994) Oncogenes and cell death. Curr Opin Genet Dev 4:120-129
34. Helene C (1991) Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur J Cancer 27:1460-1471
35. Hockenbery DM, Oltvai ZN, Yin XM, Milliamanb CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis.Cell 75:241-251
36. Hofmann M, Rudy W, Gunthert U, Zimmer SG, Zawadzki V, Zoller M, Lichtner RB, Herrlich P, Ponta H (1993) A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53:1516-1521
37. Hu QJ, Klippel A, Muslin AJ, Fantl WJ, Williams LT (1995) Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268:100-102
38. Huschtscha LI, Jeitner TM, Andersson CE, Bartier WA, Tattersall MHN (1994) Identification of apoptotic and necrotic human leukemic cells by flow eytometry. Exp Cell Res 212:161-165
39. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 259:295-300
40. Kerbel RS, Kobayashi H, Graham CH (1994) Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes? J Cell Biochem 56:37-47
41. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-245
42. Khosravi-Far R, Der CJ (1994) The Ras signal transduction pathway. Cancer Metastasis Rev 13:67-89
43. Laio Y, Tang ZY, Liu KD (1994) Protooncogenes and apoptosis. Chin J Cancer Biother 1:70-74
44. Lee EY, Chang CY, Hu N, Wang YCJ, Lai CC, Herrup K, Lee WH (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 259:288-294
45. Lin HJ, Eviner V, Prendergast GC, White E (1995) Activated H-ras rescues E1A-induced apoptosis and cooperate with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 15:4536-4544
46. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 74:957-967
47. Malcomson RD, Oren M, Wyllie AH, Harrison DJ (1995) P53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer 72:952-957
48. Marshall MS (1995) Ras target proteins in eukaryotic cells. FASEB J 9:1311-1318
49. Martin SJ, Green DR (1995) Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 18:137-153
50. McConkey DJ, Fernandez A, Trent J, Ananthaswamy HN (1995) Oncogene regulation of endonuclease activation in apoptosis. Cancer Lett 94:9-16
51. Metelev V, Agrawal S (1992) Ion-exchange high-performance liquid chromatography analysis of oligodeoxyribonucleotide phosphorothioates. Anal Biochem 200:342-346
52. Milligan JF, Matteucci MD, Martin JC (1993) Current concepts in antisense drug design. J Med Chem 36:1923-1937
53. Mirabelli CK, Crooke ST (1993) Antisense oligonucleotides in the context of modern molecular drug discovery and development. In: Antisense research and applications. Crooke ST, Bernard L (eds) CRC, Boca Raton, Fla, pp 7-35
54. Mitsuhashi BY, Filmus BJ, Shirasawa S, Sasazuki T, Kerbel RS (1995) Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumour angiogenesis. Cancer Res 55:4575-4580
55. Moore J, Boswell S, Hoffman R, Burgess G, Hromas R (1993) Mutation H-ras over-expression inhibits a random apoptotic nuclease in myeloid leukemia cells. Leuk Res 17:703-709
56. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279
57. Nooter K, Boersma AWM, Oostrum RG, Burger H, Jochemsen A, Stoter G (1995) Constitutive expression of the c-H-ras oncogene inhibit doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line. Br J Cancer 71:556-561
58. Oberhammer FA, Pavelka M, Shama S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 89:5408-5412
59. Oren M (1992) The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev 11:141-148
60. Packham G, Cleveland JL (1995) C-myc and apoptosis. Biochim Biophys Acta 1242:11-28
61. Patel T, Gores GJ (1995) Apoptosis and hepatobiliary disease. Hepatology 21:1725-1741
62. Reddy EP (1983) Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science 220:1061-1063
63. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6
64. Rose JK, Gallione CJ (1981) Nucleotide sequences of the mRNAs encoding the vesicular stomatosis G and M proteins determined from cDNA clones containing the complete coding regions. J Virol 39:519-528
65. Sakai N, Ogiso Y, Fujita H, Watari H, Koike T, Kuzumaki N (1994) Induction of apoptosis by a dominant negative H-ras mutant (116Y) in K562 cells. Exp Cell Res 215:131-136
66. Scanlon KJ, Ohta Y, Ishida H, Kijima H, Ohkawa T, Kaminski A, Tsai J, Horng G, Kashani-Sabet MK (1995) Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J 9:1288-1296
67. Schwartz LM, Osborne BA (1993) Programmed cell death, apoptosis and killer genes. Immunol Today 14:582-590
68. Shack S, Chen LC, Miller AC, Danes R, Amid D (1995) Increased susceptibility of ras-transformed cells to phenylacetate is associated with inhibition of p21ras isoprenylation and phenotypic reversion. Int J Cancer 63:124-129
69. Shaw P, Bovey R, Tardy S, Sahli R, Sordt B, Costa J (1992) Induction of apoptosis by wild-type p53 in a colon tumor-derived cell line. Proc Natl Acad Sci USA 89:4495-4499
70. Spaargaren M, Martin GA, McCorcomick F, Fernandez-Sarabia MJ, Bischoff JR (1994) The ras-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner. Biochem J 300:303-307
71. Spaargaren M, Bischoff JR, McCormick F (1995) Signal transduction by Ras-like GTPases: a potential target for anticancer drugs. Gene Expr 4:345-356
72. Stein CA, Cheng YC (1993) Antisense olignucleotides as therapeutic agents-is the bullet really magical? Science 261:1004-1012
73. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267:1445-1449
74. Stewart BW (1994) Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 17:1286-1296
75. Tabor E (1994) Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 42:357-365
76. Tang ZY (1996) Small hepatocellular carcinoma: past, present and future. Chin Med J 109:21-24
77. Thompson CB (1995) Apoptosis in pathogenesis and treatment of disease. Science 267:1456-1462
78. Wagner RW (1994) Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335
79. Wickstrom EL, Bacon TA, Gonzalez A, Freeman DL, Lyman GH, Wicksrom E (1988) Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci USA 85:1028-1032
80. Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74:777-779
81. Wong Y, Lin ZY (1996) Preliminary study on the relationship between the H-ras oncogene and the metastasis or invasion of hepatocellular carcinoma. In: Tang ZY, Ye SL (eds) Recent progress in liver cancer and hepatitis. Beijing International Academic Publishers, Beijing, p 80
82. Wood AC, Waters CM, Garner A, Hickman JA (1994) Changes in c-myc expression and kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells. Br J Cancer 69:663-669
83. Wyllie AH (1992) Apoptosis and regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 11:95-103
84. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E, Spandidos DA (1987) Rodent fibroblast tumors expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer 56:251-259
85. Zon G, Geiser TG (1991) Phosphorothioate oligonucleotides: chemistry, purification, analysis, scale-up and future direction. Anticancer Drug Des 6:539-568